Cambridge Investment Research Advisors Inc. increased its stake in Clorox Company (The) (NYSE:CLX) by 0.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,434 shares of the company’s stock after buying an additional 57 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Clorox Company (The) were worth $4,188,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. American Beacon Advisors Inc. bought a new position in Clorox Company (The) during the first quarter valued at approximately $104,000. Parkside Financial Bank & Trust increased its position in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. increased its position in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. increased its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. Finally, Zions Bancorporation increased its position in Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares in the last quarter. Hedge funds and other institutional investors own 71.26% of the company’s stock.

Shares of Clorox Company (CLX) opened at 137.50 on Tuesday. The company has a 50 day moving average price of $134.18 and a 200 day moving average price of $134.70. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company has a market capitalization of $17.75 billion, a PE ratio of 25.77 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the prior year, the business posted $1.30 EPS. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities analysts predict that Clorox Company will post $5.68 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cambridge Investment Research Advisors Inc. Has $4.19 Million Stake in Clorox Company (The) (CLX)” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/cambridge-investment-research-advisors-inc-has-4-19-million-stake-in-clorox-company-the-clx/1529648.html.

Several research analysts have recently commented on CLX shares. Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective on the stock in a report on Tuesday, July 4th. BMO Capital Markets reiterated a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a report on Thursday, May 4th. Barclays PLC reiterated an “equal weight” rating and issued a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 price objective (up previously from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. Finally, Jefferies Group LLC set a $138.00 price objective on Clorox Company (The) and gave the stock a “hold” rating in a report on Wednesday, May 3rd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $129.05.

In other news, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the transaction, the executive vice president now owns 22,069 shares in the company, valued at approximately $3,056,777.19. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the transaction, the senior vice president now owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.